Phase 3 Study of FOLFIRINOX (mFFX) +/- SBRT in Locally Advanced Pancreatic Cancer

NCT01926197 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: Oxaliplatin
DRUG: Irinotecan
DRUG: Leucovorin
DRUG: 5FU
RADIATION: Stereotactic Body Radiotherapy (SBRT)

Sponsor

Stanford University